Condensed Consolidated Interim Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Current
Cash and cash equivalents	$ 139,386	$ 151,024
Incentive and tax receivables	3,785	2,709
Prepaid expenses and other current assets	1,345	653
Total Assets	144,516	154,386
Current Liabilities
Accounts payable	3,726	4,322
Accrued liabilities - Note 4	4,915	7,295
Deferred grant income - Note 3	917	917
Total Liabilities	9,558	12,534
Commitments and Contingencies - Note 6
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share	0	0
Capital stock Authorized:200,000,000 common stock, par value $0.001 per share 82,086,511 common shares (September 30, 2023 - 82,066,511)	84	82
Additional paid-in capital	447,345	434,839
Share proceeds receivable	(234)	0
Accumulated deficit	(312,237)	(293,069)
Total Stockholders' Equity	134,958	141,852
Total Liabilities and Stockholders' Equity	$ 144,516	$ 154,386

No definition available.

Name:	avxl_ShareProceedsReceivable
Namespace Prefix:	avxl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).